Search

From regulatory hurdles to patient recruitment challenges; how can pharma improve its clinical trials?

How small molecule-focused CDMOs can help companies navigate the impact of the Inflation Reduction Act.

How to mitigate the risks involved in highly potent APIs.

How can pharma improve patient access to medications? Christine Marsh of Boehringer Ingelheim offers her view.

Why we need to shift from reactive to proactive measures in tackling global health challenges.

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

How digital technology has, and will continue to, augment scientific data collection and discovery

How will the biopharma industry evolve over the next 10 years? We speak with experts from Sartorius and the USP.

Developing science is good; developing successful commercialization strategies is great.

Alfred Marchler and Peter Hirst discuss the biggest disruptors shaping the next decade.